2023 Q4 Form 10-K Financial Statement

#000183018824000010 Filed on March 15, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $116.8M $421.5M $115.1M
YoY Change 1.5% -11.64%
Cost Of Revenue $95.21M $341.7M $93.50M
YoY Change 1.83% -4.59% -28.08%
Gross Profit $21.62M $79.73M $21.60M
YoY Change 0.09% -32.89% -39.5%
Gross Profit Margin 18.51% 18.92% 18.77%
Selling, General & Admin $18.40M $65.09M $10.70M
YoY Change 71.94% 32.04% 4864.51%
% of Gross Profit 85.09% 81.65% 49.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $81.63K $199.4K $100.0K
YoY Change -18.37% -44.61% 11.11%
% of Gross Profit 0.38% 0.25% 0.46%
Operating Expenses $18.44M $65.09M $10.80M
YoY Change 70.76% 30.97% 4910.9%
Operating Profit $3.178M $14.63M $10.80M
YoY Change -70.57% -423.41% -69.56%
Interest Expense -$69.06M $112.1M $300.0K
YoY Change -23119.8% 22317.61% 4487.16%
% of Operating Profit -2173.0% 766.09% 2.78%
Other Income/Expense, Net -$174.8K -$3.763M -$200.0K
YoY Change -12.61% 1781.31% -145.79%
Pretax Income -$66.06M $128.0M $10.90M
YoY Change -706.02% 1488.95% 4685.74%
Income Tax $584.7K $2.957M
% Of Pretax Income 2.31%
Net Earnings -$66.64M $125.1M $10.90M
YoY Change -711.38% 1668.06% 4685.74%
Net Earnings / Revenue -57.04% 29.67% 9.47%
Basic Earnings Per Share $2.74
Diluted Earnings Per Share -$1.38 $2.35 $0.23
COMMON SHARES
Basic Shares Outstanding 45.64M shares
Diluted Shares Outstanding 55.77M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.67M $56.67M $12.20M
YoY Change 364.52% 364.52% 4729.77%
Cash & Equivalents $56.67M $56.67M $37.00K
Short-Term Investments
Other Short-Term Assets $7.764M $7.675M $3.600M
YoY Change 115.65% 155.83% 1399.5%
Inventory $182.8M $182.8M $180.2M
Prepaid Expenses $20.02K
Receivables $1.661M $1.750M $2.000M
Other Receivables $698.2K $698.2K $1.400M
Total Short-Term Assets $249.6M $249.6M $56.70K
YoY Change 440134.47% 25.18% -88.49%
LONG-TERM ASSETS
Property, Plant & Equipment $1.074M $6.485M $1.386M
YoY Change -22.5% 170.21%
Goodwill $5.707M $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.430M $1.430M $200.0K
YoY Change 615.09% 615.09% -99.94%
Other Assets $2.405M $2.405M
YoY Change
Total Long-Term Assets $49.04M $49.04M $349.2M
YoY Change -85.95% 451.05% 1.2%
TOTAL ASSETS
Total Short-Term Assets $249.6M $249.6M $56.70K
Total Long-Term Assets $49.04M $49.04M $349.2M
Total Assets $298.6M $298.6M $349.2M
YoY Change -14.48% 43.37% 1.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.68M $38.68M $100.3K
YoY Change 38464.3% 75.03% 84.41%
Accrued Expenses $13.92M $13.92M $3.660M
YoY Change 280.27% 124.5% 2950.24%
Deferred Revenue $0.00 $305.7K
YoY Change -100.0%
Short-Term Debt $80.45M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.73M $53.73M $4.446M
YoY Change 1108.44% 89.85% 1438.26%
LONG-TERM LIABILITIES
Long-Term Debt $148.5M $148.5M $120.8M
YoY Change 22.92% 22.92%
Other Long-Term Liabilities $127.6M $127.6M
YoY Change 42436.98%
Total Long-Term Liabilities $276.1M $276.1M $120.8M
YoY Change 128.56% 127.99% 478.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.73M $53.73M $4.446M
Total Long-Term Liabilities $276.1M $276.1M $120.8M
Total Liabilities $329.8M $329.8M $5.977M
YoY Change 5418.2% 120.92% -71.75%
SHAREHOLDERS EQUITY
Retained Earnings -$33.98M -$5.355M
YoY Change 534.55% -74.06%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$31.18M -$31.18M -$5.354M
YoY Change
Total Liabilities & Shareholders Equity $298.6M $298.6M $349.2M
YoY Change -14.48% 43.37% 1.07%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$66.64M $125.1M $10.90M
YoY Change -711.38% 1668.06% 4685.74%
Depreciation, Depletion And Amortization $81.63K $199.4K $100.0K
YoY Change -18.37% -44.61% 11.11%
Cash From Operating Activities -$17.26M $28.22M $14.96M
YoY Change -215.4% -2332.17% -16742.56%
INVESTING ACTIVITIES
Capital Expenditures $103.1K $162.3K $50.00K
YoY Change 106.2% -4.51% -50.0%
Acquisitions $24.30M
YoY Change
Other Investing Activities -$22.10M -$24.14M $0.00
YoY Change 60246.65%
Cash From Investing Activities -$22.20M -$24.30M -$60.00K
YoY Change 36905.88% -2745.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.90M $40.51M -22.04M
YoY Change -167.58% 31060.57%
NET CHANGE
Cash From Operating Activities -17.26M $28.22M 14.96M
Cash From Investing Activities -22.20M -$24.30M -60.00K
Cash From Financing Activities 14.90M $40.51M -22.04M
Net Change In Cash -24.57M $44.43M -7.140M
YoY Change 244.15% -20678.38% 7843.04%
FREE CASH FLOW
Cash From Operating Activities -$17.26M $28.22M $14.96M
Capital Expenditures $103.1K $162.3K $50.00K
Free Cash Flow -$17.37M $28.06M $14.91M
YoY Change -216.48% -2056.31% -7951.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3762613 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
230692 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
137086 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001830188
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#GainLossOnDerivativeInstrumentsNetPretax
CY2021Q1 uhg Defined Contribution Plan Minimum Service Period
DefinedContributionPlanMinimumServicePeriod
P3M
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39936
CY2023 dei Entity Registrant Name
EntityRegistrantName
UNITED HOMES GROUP, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3460766
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
917 Chapin Road
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Chapin
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
SC
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
29036
CY2023 dei City Area Code
CityAreaCode
844
CY2023 dei Local Phone Number
LocalPhoneNumber
766-4663
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
83664251 usd
CY2023 dei Auditor Firm
AuditorFirmId
686
CY2023 dei Auditor Name
AuditorName
FORVIS, LLP
CY2023 dei Auditor Location
AuditorLocation
Tysons, VA
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56671471 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12238835 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1661206 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1976334 usd
CY2023Q4 uhg Inventory Homes Under Construction And Finished Homes
InventoryHomesUnderConstructionAndFinishedHomes
147582130 usd
CY2022Q4 uhg Inventory Homes Under Construction And Finished Homes
InventoryHomesUnderConstructionAndFinishedHomes
163997487 usd
CY2023Q4 uhg Inventory Developed Lots And Land Held Development And Sale
InventoryDevelopedLotsAndLandHeldDevelopmentAndSale
35227572 usd
CY2022Q4 uhg Inventory Developed Lots And Land Held Development And Sale
InventoryDevelopedLotsAndLandHeldDevelopmentAndSale
16205448 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
88000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1437235 usd
CY2023Q4 uhg Related Party Note Receivable
RelatedPartyNoteReceivable
610189 usd
CY2022Q4 uhg Related Party Note Receivable
RelatedPartyNoteReceivable
0 usd
CY2023Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
33015812 usd
CY2022Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
3804436 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1430177 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
186086 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2405417 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1073961 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385698 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5411192 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1001277 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
7763565 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
6112044 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5706636 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q4 us-gaap Assets
Assets
298647328 usd
CY2022Q4 us-gaap Assets
Assets
208344880 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
38680764 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
22077240 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80451429 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
120797006 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5565320 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1001277 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8353824 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5465321 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1128804 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
127610943 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
68038780 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
329829864 usd
CY2022Q4 us-gaap Liabilities
Liabilities
149340844 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2794493 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1422630 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33981864 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
57577672 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31182536 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
59004036 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
298647328 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
208344880 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
477045949 usd
CY2023 us-gaap Gross Profit
GrossProfit
79725620 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65094444 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49685730 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
14631176 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
69121516 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1244091 usd
CY2023 uhg Derivative Gain Loss On Derivative Net And Fair Value Adjustment Of Warrants
DerivativeGainLossOnDerivativeNetAndFairValueAdjustmentOfWarrants
115904646 usd
CY2022 uhg Derivative Gain Loss On Derivative Net And Fair Value Adjustment Of Warrants
DerivativeGainLossOnDerivativeNetAndFairValueAdjustmentOfWarrants
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
128017300 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69489294 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2957016 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
125060284 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
69489294 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.74
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.35
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.81
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45639431 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37347347 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55768890 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38452827 shares
CY2021Q4 uhg Retroactive Application Of Recapitalization Value
RetroactiveApplicationOfRecapitalizationValue
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
66558412 usd
CY2022 uhg Stockholders Equity Period Decrease Increase From Distributions And Net Transfer To Shareholders And Other Affiliates
StockholdersEquityPeriodDecreaseIncreaseFromDistributionsAndNetTransferToShareholdersAndOtherAffiliates
78466300 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1422630 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
69489294 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
59004036 usd
CY2023 uhg Stockholders Equity Period Decrease Increase From Distributions And Net Transfer To Shareholders And Other Affiliates
StockholdersEquityPeriodDecreaseIncreaseFromDistributionsAndNetTransferToShareholdersAndOtherAffiliates
4193093 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2571106 usd
CY2023 uhg Adjustments To Additional Paid In Capital Forfeiture Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalForfeitureOfPrivatePlacementWarrants
890001 usd
CY2023 uhg Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
17589874 usd
CY2023 uhg Stock Issued During Period Value Pipe Investment
StockIssuedDuringPeriodValuePipeInvestment
9501915 usd
CY2023 uhg Stock Issued During Period Value Lock Up Agreement
StockIssuedDuringPeriodValueLockUpAgreement
4236 usd
CY2023 uhg Adjustments To Additional Paid In Capital Recognition Of Derivative Liability Related To Earnout
AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeLiabilityRelatedToEarnout
242211404 usd
CY2023 uhg Adjustments To Additional Paid In Capital Recognition Of Derivative Liability Related To Equity Incentive Plan
AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeLiabilityRelatedToEquityIncentivePlan
1279139 usd
CY2023 uhg Adjustments To Additional Paid In Capital Earnout Stock Based Compensation Expense For Uhg Employee Options
AdjustmentsToAdditionalPaidInCapitalEarnoutStockBasedCompensationExpenseForUhgEmployeeOptions
4448077 usd
CY2023 uhg Adjustments To Additional Paid In Capital Reverse Recapitalization Transaction Costs
AdjustmentsToAdditionalPaidInCapitalReverseRecapitalizationTransactionCosts
2932426 usd
CY2023 uhg Adjustments To Additional Paid In Capital Reclassification Of Negative Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapitalReclassificationOfNegativeAdditionalPaidInCapital
0 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
133979 usd
CY2023 uhg Shares Issued Value Share Based Payment Arrangement Options Forfeited
SharesIssuedValueShareBasedPaymentArrangementOptionsForfeited
487739 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
257721 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
125060284 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-31182536 usd
CY2023 uhg Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
373.47
CY2023 us-gaap Net Income Loss
NetIncomeLoss
125060284 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
69489294 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
192248 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1244091 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
137086 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
236103 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
355566 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-329533 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6966 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
981675 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
404146 usd
CY2023 uhg Non Cash Interest Income
NonCashInterestIncome
38455 usd
CY2022 uhg Non Cash Interest Income
NonCashInterestIncome
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
7019183 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1422630 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1097281 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
525434 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10988922 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
181000 usd
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-153819 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-109684 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1349235 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1437235 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22247292 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26673147 usd
CY2023 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
25380030 usd
CY2022 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
858435 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
143791 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2408936 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2617918 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11674490 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6663814 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-943153 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-525434 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
426933 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2175776 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1007089 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28224880 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34616722 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
162328 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171685 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66100 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13808 usd
CY2023 uhg Proceeds From Promissory Note Issued In Exchange For Sale Of Property Plant And Equipment
ProceedsFromPromissoryNoteIssuedInExchangeForSaleOfPropertyPlantAndEquipment
93286 usd
CY2022 uhg Proceeds From Promissory Note Issued In Exchange For Sale Of Property Plant And Equipment
ProceedsFromPromissoryNoteIssuedInExchangeForSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
24298043 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 usd
CY2022 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
49000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24300985 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-206877 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
72500000 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
179336312 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
105055992 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
170810631 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
136773 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10851187 usd
CY2023 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
142536 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
918453 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
105000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3240984 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
17896302 usd
CY2022 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
54175689 usd
CY2023 uhg Changes In Net Due To And Due From Shareholders And Other Affiliates
ChangesInNetDueToAndDueFromShareholdersAndOtherAffiliates
0 usd
CY2022 uhg Changes In Net Due To And Due From Shareholders And Other Affiliates
ChangesInNetDueToAndDueFromShareholdersAndOtherAffiliates
-37816087 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
71500000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023 uhg Proceeds From Pipe Investment And Lock Up
ProceedsFromPipeInvestmentAndLockUp
4720427 usd
CY2022 uhg Proceeds From Pipe Investment And Lock Up
ProceedsFromPipeInvestmentAndLockUp
0 usd
CY2023 uhg Proceeds From Business Combination Net Of Spac Transaction Costs
ProceedsFromBusinessCombinationNetOfSpacTransactionCosts
30336068 usd
CY2022 uhg Proceeds From Business Combination Net Of Spac Transaction Costs
ProceedsFromBusinessCombinationNetOfSpacTransactionCosts
0 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
257721 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2023 uhg Payment Of Transaction Costs
PaymentOfTransactionCosts
12134293 usd
CY2022 uhg Payment Of Transaction Costs
PaymentOfTransactionCosts
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5765 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40508741 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73675897 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44432636 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39266052 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12238835 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51504887 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56671471 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12238835 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
15682821 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5000196 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5148000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 uhg Additions Of Right Of Use Lease Assets And Liabilities
AdditionsOfRightOfUseLeaseAssetsAndLiabilities
5300103 usd
CY2022 uhg Additions Of Right Of Use Lease Assets And Liabilities
AdditionsOfRightOfUseLeaseAssetsAndLiabilities
1585096 usd
CY2023 uhg Acquisition Of Developed Lots From Related Parties In Settlement Of Due From Other Affiliates
AcquisitionOfDevelopedLotsFromRelatedPartiesInSettlementOfDueFromOtherAffiliates
0 usd
CY2022 uhg Acquisition Of Developed Lots From Related Parties In Settlement Of Due From Other Affiliates
AcquisitionOfDevelopedLotsFromRelatedPartiesInSettlementOfDueFromOtherAffiliates
13504316 usd
CY2023 uhg Debt Conversion
DebtConversion
0 usd
CY2022 uhg Debt Conversion
DebtConversion
1414681 usd
CY2023 uhg Transfer Of Co Obligor Debt To Land Development Affiliate
TransferOfCoObligorDebtToLandDevelopmentAffiliate
0 usd
CY2022 uhg Transfer Of Co Obligor Debt To Land Development Affiliate
TransferOfCoObligorDebtToLandDevelopmentAffiliate
21160 usd
CY2023 us-gaap Notes Issued1
NotesIssued1
665020 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2023 uhg Transfer Of Co Obligor Debt To Affiliate
TransferOfCoObligorDebtToAffiliate
8340545 usd
CY2022 uhg Transfer Of Co Obligor Debt To Affiliate
TransferOfCoObligorDebtToAffiliate
0 usd
CY2023 uhg Transfer Of Guarantor From Gsh To Shareholder
TransferOfGuarantorFromGshToShareholder
2841034 usd
CY2022 uhg Transfer Of Guarantor From Gsh To Shareholder
TransferOfGuarantorFromGshToShareholder
0 usd
CY2023 uhg Noncash Distribution To Owner S Of Other Affiliates
NoncashDistributionToOwnerSOfOtherAffiliates
12671122 usd
CY2022 uhg Noncash Distribution To Owner S Of Other Affiliates
NoncashDistributionToOwnerSOfOtherAffiliates
0 usd
CY2023 uhg Earnest Money Receivable From Other Affiliates
EarnestMoneyReceivableFromOtherAffiliates
2521626 usd
CY2022 uhg Earnest Money Receivable From Other Affiliates
EarnestMoneyReceivableFromOtherAffiliates
0 usd
CY2023 uhg Recognition Of Previously Capitalized Deferred Transaction Costs
RecognitionOfPreviouslyCapitalizedDeferredTransactionCosts
2932426 usd
CY2022 uhg Recognition Of Previously Capitalized Deferred Transaction Costs
RecognitionOfPreviouslyCapitalizedDeferredTransactionCosts
0 usd
CY2023 uhg Modification To Existing Lease
ModificationToExistingLease
-40968 usd
CY2022 uhg Modification To Existing Lease
ModificationToExistingLease
0 usd
CY2023 uhg Recognition Of Derivative Liability Related To Earnout
RecognitionOfDerivativeLiabilityRelatedToEarnout
242211404 usd
CY2022 uhg Recognition Of Derivative Liability Related To Earnout
RecognitionOfDerivativeLiabilityRelatedToEarnout
0 usd
CY2023 uhg Recognition Of Derivative Liability Related To Equity Incentive Plan
RecognitionOfDerivativeLiabilityRelatedToEquityIncentivePlan
1279139 usd
CY2022 uhg Recognition Of Derivative Liability Related To Equity Incentive Plan
RecognitionOfDerivativeLiabilityRelatedToEquityIncentivePlan
0 usd
CY2023 uhg Recognition Of Warrant Liability Upon Business Combination
RecognitionOfWarrantLiabilityUponBusinessCombination
1531000 usd
CY2022 uhg Recognition Of Warrant Liability Upon Business Combination
RecognitionOfWarrantLiabilityUponBusinessCombination
0 usd
CY2023 uhg Forfeiture Of Private Placement Warrants Upon Business Combination
ForfeitureOfPrivatePlacementWarrantsUponBusinessCombination
890001 usd
CY2022 uhg Forfeiture Of Private Placement Warrants Upon Business Combination
ForfeitureOfPrivatePlacementWarrantsUponBusinessCombination
0 usd
CY2023 uhg Noncash Or Part Noncash Acquisition Contingent Consideration Liability
NoncashOrPartNoncashAcquisitionContingentConsiderationLiability
1707000 usd
CY2022 uhg Noncash Or Part Noncash Acquisition Contingent Consideration Liability
NoncashOrPartNoncashAcquisitionContingentConsiderationLiability
0 usd
CY2023 uhg Noncash Or Part Noncash Acquisition Contingent Liability
NoncashOrPartNoncashAcquisitionContingentLiability
300000 usd
CY2022 uhg Noncash Or Part Noncash Acquisition Contingent Liability
NoncashOrPartNoncashAcquisitionContingentLiability
0 usd
CY2023 us-gaap Stock Issued1
StockIssued1
39933707 usd
CY2022 us-gaap Stock Issued1
StockIssued1
0 usd
CY2023 uhg Recognition Of Deferred Tax Asset Upon Business Combination
RecognitionOfDeferredTaxAssetUponBusinessCombination
1589600 usd
CY2022 uhg Recognition Of Deferred Tax Asset Upon Business Combination
RecognitionOfDeferredTaxAssetUponBusinessCombination
0 usd
CY2023 uhg Recognition Of Income Tax Payable Upon Business Combination
RecognitionOfIncomeTaxPayableUponBusinessCombination
701871 usd
CY2022 uhg Recognition Of Income Tax Payable Upon Business Combination
RecognitionOfIncomeTaxPayableUponBusinessCombination
0 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
-3588110 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 usd
CY2023 uhg Noncash Exercise Of Stock Warrants
NoncashExerciseOfStockWarrants
-75 usd
CY2022 uhg Noncash Exercise Of Stock Warrants
NoncashExerciseOfStockWarrants
0 usd
CY2023 uhg Noncash Exercise Of Employee Stock Options
NoncashExerciseOfEmployeeStockOptions
-128214 usd
CY2022 uhg Noncash Exercise Of Employee Stock Options
NoncashExerciseOfEmployeeStockOptions
0 usd
CY2023 uhg Forfeiture Of Employee Stock Options
ForfeitureOfEmployeeStockOptions
-487739 usd
CY2022 uhg Forfeiture Of Employee Stock Options
ForfeitureOfEmployeeStockOptions
0 usd
CY2023 uhg Non Cash Investing And Financing Activities
NonCashInvestingAndFinancingActivities
326823288 usd
CY2022 uhg Non Cash Investing And Financing Activities
NonCashInvestingAndFinancingActivities
16525253 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4700000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
47594936 shares
CY2023Q1 uhg Ownership Percentage
OwnershipPercentage
1
CY2023Q1 uhg Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
128600000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4700000 usd
CY2023Q1 uhg Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
25700000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Management continually evaluates the estimates used to prepare the Consolidated Financial Statements and updates those estimates as necessary. In general, UHG’s estimates are based on historical experience, on information from third party professionals, and other various assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ materially from those estimates made by management.</span>
CY2023 uhg Deposit In Transit Period
DepositInTransitPeriod
P5D
CY2022Q4 uhg Deposits In Transit
DepositsInTransit
0 usd
CY2023Q4 uhg Deposits In Transit
DepositsInTransit
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
109080 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
8846666 usd
CY2022Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
0 usd
CY2023Q4 uhg Inventory Developed Lots
InventoryDevelopedLots
26380906 usd
CY2022Q4 uhg Inventory Developed Lots
InventoryDevelopedLots
16205448 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
125623133 usd
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
141863561 usd
CY2023Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
21958997 usd
CY2022Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
22133926 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
49000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1244091 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
137086 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1430177 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
186086 usd
CY2022 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2023 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
49000 usd
CY2023 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q4 uhg Reverse Recapitalization Deferred Transaction Costs
ReverseRecapitalizationDeferredTransactionCosts
0 usd
CY2022Q4 uhg Reverse Recapitalization Deferred Transaction Costs
ReverseRecapitalizationDeferredTransactionCosts
2491459 usd
CY2023Q4 uhg Revenue Number Of Performance Obligations
RevenueNumberOfPerformanceObligations
1 performanceobligation
CY2023 uhg Revenue From Contract With Customer Consideration At Closing Period
RevenueFromContractWithCustomerConsiderationAtClosingPeriod
P5D
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
88562 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
611343 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
305701 usd
CY2022 us-gaap Contract With Customer Receivable Credit Loss Expense Reversal
ContractWithCustomerReceivableCreditLossExpenseReversal
0 usd
CY2023 us-gaap Contract With Customer Receivable Credit Loss Expense Reversal
ContractWithCustomerReceivableCreditLossExpenseReversal
0 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2132057 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2709488 usd
CY2023Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
982981 usd
CY2023Q1 uhg Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
21495794 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q1 uhg Warrants And Rights Outstanding Transfer Sale Assignment Threshold Term
WarrantsAndRightsOutstandingTransferSaleAssignmentThresholdTerm
P30D
CY2023 uhg Common Stock Warrants Exercised
CommonStockWarrantsExercised
0 shares
CY2023Q1 uhg Number Of Freestanding Financial Instruments
NumberOfFreestandingFinancialInstruments
2 financialinstrument
CY2023Q1 uhg Proceeds Allocated To Notes
ProceedsAllocatedToNotes
70200000 usd
CY2023Q1 uhg Proceeds Allocated To Shares
ProceedsAllocatedToShares
4800000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
421474101 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
477045949 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
128017300 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69489294 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5706636 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q4 us-gaap Assets
Assets
298647328 usd
CY2022Q4 us-gaap Assets
Assets
208344880 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5706636 usd
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
uhg Number Of Real Estate Properties Acquired
NumberOfRealEstatePropertiesAcquired
50 lot
CY2023 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
467687204 usd
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
525280854 usd
CY2023 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
128726891 usd
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
72973203 usd
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
133400000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
127610943 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1888000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
129498943 usd
CY2022Q4 uhg Fair Value Transfer From Levels Amount
FairValueTransferFromLevelsAmount
0 usd
CY2023Q4 uhg Fair Value Transfer From Levels Amount
FairValueTransferFromLevelsAmount
0 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1250460 usd
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1190318 usd
CY2023 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
17203950 usd
CY2022 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
5515372 usd
CY2023 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9385970 usd
CY2022 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
5455230 usd
CY2023 uhg Real Estate Inventory Capitalized Interest Costs Interest Expense
RealEstateInventoryCapitalizedInterestCostsInterestExpense
6042358 usd
CY2022 uhg Real Estate Inventory Capitalized Interest Costs Interest Expense
RealEstateInventoryCapitalizedInterestCostsInterestExpense
0 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
3026082 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
1250460 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1570501 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3022629 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
496540 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1636931 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1073961 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385698 usd
CY2023 uhg Construction Contractor Short Term Contract Duration
ConstructionContractorShortTermContractDuration
P1Y
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80451429 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
120797006 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M28D
CY2022Q4 uhg Related Party Transaction Number Homes Sold
RelatedPartyTransactionNumberHomesSold
19 home
CY2023 uhg Overhead Costs Allocated To Related Party
OverheadCostsAllocatedToRelatedParty
412970 usd
CY2023 uhg Street Maintenance Related Party
StreetMaintenanceRelatedParty
205606 usd
CY2023Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
33015812 usd
CY2022Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
3804436 usd
CY2023Q4 us-gaap Land Under Purchase Options Not Recorded
LandUnderPurchaseOptionsNotRecorded
231333171 usd
CY2022Q4 us-gaap Land Under Purchase Options Not Recorded
LandUnderPurchaseOptionsNotRecorded
65451928 usd
CY2023Q4 uhg Purchase Option Total Contract Value
PurchaseOptionTotalContractValue
264348983 usd
CY2022Q4 uhg Purchase Option Total Contract Value
PurchaseOptionTotalContractValue
69256364 usd
CY2023Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
33015812 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1371412 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1275594 usd
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1156027 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1301796 usd
CY2023Q4 uhg Number Of Office Spaces With Third Party
NumberOfOfficeSpacesWithThirdParty
1 officespace
CY2023Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P5Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1099406 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
555806 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
48086 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
92285 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0968
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0490
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y5M8D
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1410657 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1545216 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1438929 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1437794 usd
CY2023Q4 uhg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1105287 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6937883 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1372563 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5565320 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
319436 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
94386 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
870567 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.81
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3350000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.38
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2053 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.81
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
332266 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.37
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3886248 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.72
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
189620 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.81
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4435957 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7460132 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1065595 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2539057 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
195830 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14460799 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M1D
CY2023Q4 uhg Derivative Instrument Contingent Consideration Liability Units Of Account
DerivativeInstrumentContingentConsiderationLiabilityUnitsOfAccount
2 unit
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4457712 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1117221 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5574933 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2041270 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-576647 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2617917 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2957016 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
25674482 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
305959 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003
CY2023 uhg Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Liabilities Amount
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilitiesAmount
-24301964 usd
CY2023 uhg Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Liabilities Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilitiesPercent
-0.199
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
254097 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.002
CY2023 uhg Effective Income Tax Rate Reconciliation Change In Tax Status Amount
EffectiveIncomeTaxRateReconciliationChangeInTaxStatusAmount
1024442 usd
CY2023 uhg Effective Income Tax Rate Reconciliation Change In Tax Status Percent
EffectiveIncomeTaxRateReconciliationChangeInTaxStatusPercent
0.008
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2957016 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.024
CY2023Q4 uhg Deferred Tax Assets Uniform Capitalization Rules
DeferredTaxAssetsUniformCapitalizationRules
898412 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
324798 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
260960 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1643593 usd
CY2023Q4 uhg Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
407725 usd
CY2023Q4 uhg Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
1388547 usd
CY2023Q4 uhg Deferred Tax Assets Start Up And Organizations Costs
DeferredTaxAssetsStartUpAndOrganizationsCosts
1582745 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
82210 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6588990 usd
CY2023Q4 uhg Deferred Tax Liabilities Adjustments After Accounting Method Change
DeferredTaxLiabilitiesAdjustmentsAfterAccountingMethodChange
650714 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
1332223 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
635329 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
202969 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1350092 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
12246 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4183573 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2405417 usd
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay One
DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPayOne
0.03
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Match One
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne
1
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Match Two
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo
0.50
CY2021Q1 uhg Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay Two
DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPayTwo
0.02
CY2021Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2021Q1 uhg Defined Contribution Plan Vesting Percentage After Completing Six Years Of Service
DefinedContributionPlanVestingPercentageAfterCompletingSixYearsOfService
1
CY2021Q1 uhg Defined Contribution Plan Service Term Required For Full Vesting
DefinedContributionPlanServiceTermRequiredForFullVesting
P6Y
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
241466 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
174184 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
125060284 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
69489294 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
125060284 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69489294 usd
CY2023 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
6184809 usd
CY2022 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45639431 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37347347 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
9250187 shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
659503 shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
713386 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55768890 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38452827 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.74
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.35
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.81
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
69211 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
21886379 shares

Files In Submission

Name View Source Status
0001830188-24-000010-index-headers.html Edgar Link pending
0001830188-24-000010-index.html Edgar Link pending
0001830188-24-000010.txt Edgar Link pending
0001830188-24-000010-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uhg-20231231.htm Edgar Link pending
uhg-20231231.xsd Edgar Link pending
uhg-20231231xex1017xexecut.htm Edgar Link pending
uhg-20231231xexx1021xwfbam.htm Edgar Link pending
uhg-20231231xexx211.htm Edgar Link pending
uhg-20231231xexx231xforvis.htm Edgar Link pending
uhg-20231231xexx311.htm Edgar Link pending
uhg-20231231xexx312.htm Edgar Link pending
uhg-20231231xexx321.htm Edgar Link pending
uhg-20231231xexx322.htm Edgar Link pending
uhg-20231231xexx44xdescrip.htm Edgar Link pending
uhg-20231231xexx971xclawba.htm Edgar Link pending
uhg-20231231_def.xml Edgar Link unprocessable
uhg-20231231_lab.xml Edgar Link unprocessable
uhg-20231231_pre.xml Edgar Link unprocessable
uhg-20231231_htm.xml Edgar Link completed
uhg-20231231_cal.xml Edgar Link unprocessable